MedTrace Logo

Carotid Risk Prediction (CRISP) Consortium

NCT04448353 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2021-02-04

No results posted yet for this study

Summary

Develop adverse event prediction and plaque phenotype classification models for patients with known or suspected carotid artery disease.

Conditions

  • Carotid Atherosclerosis

Interventions

DIAGNOSTIC_TEST

vascuCAP

adverse event and phenotype classification model

Sponsors & Collaborators

  • University of Maryland, College Park

    collaborator OTHER

  • Elucid Bioimaging Inc.

    lead INDUSTRY

Principal Investigators

  • Brajesh K. Lal, MD · University of Maryland, College Park

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2021-12-15
Completion
2022-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04448353 on ClinicalTrials.gov